Evaluation of mitoxantrone cardiac toxicity by nuclear angiography and endomyocardial biopsy: an update View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1985-06

AUTHORS

Robert S. Benjamin, Sant P. Chawla, Michael S. Ewer, C. Humberto Carrasco, Bruce Mackay, Frankie Holmes

ABSTRACT

Sixty-six patients who underwent endomyocardial biopsy for detection of mitoxantrone (Novantrone┬«; dihydroxyanthracenedione) cardiac toxicity were evaluated. All but one had breast cancer, 29 had received prior doxorubicin and 29 of the 37 patients who had not had prior doxorubicin received it or another anthracycline subsequently. Endomyocardial biopsy was carried out initially after four courses of chemotherapy with increasing intervals thereafter. Although cardiac ejection fraction was determined before each course of chemotherapy, our data are limited to cardiac ejection fractions from our own institution which were repeated approximately every four courses. Endomyocardial biopsy changes consisting of dilatation of the sarcoplasmic reticulum with vacuole formation, and myofibrillar dropout are similar to the early changes of anthracycline cardiomyopathy.While there was a slight suggestion of increasing biopsy grade with increasing mitoxantrone dose, no significant changes in cardiac ejection fraction could be associated, regardless of prior doxorubicin therapy. We concluded that mitoxantrone does show morphologic evidence of cardiac toxicity; however, the structural changes are minor and are haemodynamically insignificant. Determination of how much mitoxantrone treatment may contribute to the deterioration of pre-existing doxorubicin damage must await the outcome of longer follow-up. More... »

PAGES

117-121

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00174158

DOI

http://dx.doi.org/10.1007/bf00174158

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1005025040

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/4019116


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angiocardiography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anthraquinones", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Biopsy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Doxorubicin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Failure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Microscopy, Electron", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mitoxantrone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Myocardium", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, TX, U.S.A.", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Medical Oncology, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, TX, U.S.A."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Benjamin", 
        "givenName": "Robert S.", 
        "id": "sg:person.01200333274.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200333274.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, TX, U.S.A.", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Medical Oncology, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, TX, U.S.A."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chawla", 
        "givenName": "Sant P.", 
        "id": "sg:person.0661314541.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661314541.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Internal Medicine, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, TX, U.S.A.", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Internal Medicine, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, TX, U.S.A."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ewer", 
        "givenName": "Michael S.", 
        "id": "sg:person.01205616545.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01205616545.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Diagnostic Radiology, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, TX, U.S.A.", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Diagnostic Radiology, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, TX, U.S.A."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carrasco", 
        "givenName": "C. Humberto", 
        "id": "sg:person.0661361305.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661361305.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pathology, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, TX, U.S.A.", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Pathology, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, TX, U.S.A."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mackay", 
        "givenName": "Bruce", 
        "id": "sg:person.0633513567.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633513567.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Medical Oncology, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, TX, U.S.A.", 
          "id": "http://www.grid.ac/institutes/grid.240145.6", 
          "name": [
            "Department of Medical Oncology, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, TX, U.S.A."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Holmes", 
        "givenName": "Frankie", 
        "id": "sg:person.01347717057.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01347717057.57"
        ], 
        "type": "Person"
      }
    ], 
    "datePublished": "1985-06", 
    "datePublishedReg": "1985-06-01", 
    "description": "Sixty-six patients who underwent endomyocardial biopsy for detection of mitoxantrone (Novantrone\u00ae; dihydroxyanthracenedione) cardiac toxicity were evaluated. All but one had breast cancer, 29 had received prior doxorubicin and 29 of the 37 patients who had not had prior doxorubicin received it or another anthracycline subsequently. Endomyocardial biopsy was carried out initially after four courses of chemotherapy with increasing intervals thereafter. Although cardiac ejection fraction was determined before each course of chemotherapy, our data are limited to cardiac ejection fractions from our own institution which were repeated approximately every four courses. Endomyocardial biopsy changes consisting of dilatation of the sarcoplasmic reticulum with vacuole formation, and myofibrillar dropout are similar to the early changes of anthracycline cardiomyopathy.While there was a slight suggestion of increasing biopsy grade with increasing mitoxantrone dose, no significant changes in cardiac ejection fraction could be associated, regardless of prior doxorubicin therapy. We concluded that mitoxantrone does show morphologic evidence of cardiac toxicity; however, the structural changes are minor and are haemodynamically insignificant. Determination of how much mitoxantrone treatment may contribute to the deterioration of pre-existing doxorubicin damage must await the outcome of longer follow-up.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/bf00174158", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094201", 
        "issn": [
          "0167-6997", 
          "1573-0646"
        ], 
        "name": "Investigational New Drugs", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "3"
      }
    ], 
    "keywords": [
      "cardiac ejection fraction", 
      "courses of chemotherapy", 
      "endomyocardial biopsy", 
      "ejection fraction", 
      "cardiac toxicity", 
      "prior doxorubicin therapy", 
      "mitoxantrone dose", 
      "mitoxantrone treatment", 
      "biopsy changes", 
      "biopsy grade", 
      "nuclear angiography", 
      "doxorubicin therapy", 
      "breast cancer", 
      "early changes", 
      "morphologic evidence", 
      "biopsy", 
      "sarcoplasmic reticulum", 
      "chemotherapy", 
      "patients", 
      "anthracyclines", 
      "vacuole formation", 
      "toxicity", 
      "significant changes", 
      "doxorubicin", 
      "slight suggestion", 
      "course", 
      "angiography", 
      "dilatation", 
      "therapy", 
      "cancer", 
      "mitoxantrone", 
      "dose", 
      "outcomes", 
      "treatment", 
      "changes", 
      "own institution", 
      "grade", 
      "damage", 
      "deterioration", 
      "interval", 
      "evidence", 
      "fraction", 
      "reticulum", 
      "evaluation", 
      "dropout", 
      "update", 
      "structural changes", 
      "data", 
      "institutions", 
      "detection", 
      "suggestions", 
      "formation", 
      "determination"
    ], 
    "name": "Evaluation of mitoxantrone cardiac toxicity by nuclear angiography and endomyocardial biopsy: an update", 
    "pagination": "117-121", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1005025040"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00174158"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "4019116"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00174158", 
      "https://app.dimensions.ai/details/publication/pub.1005025040"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-11-24T20:46", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/article/article_189.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/bf00174158"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00174158'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00174158'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00174158'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00174158'


 

This table displays all metadata directly associated to this object as RDF triples.

219 TRIPLES      20 PREDICATES      95 URIs      87 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00174158 schema:about N07950c68e4064a93884635a0afb39189
2 N08d86d0eb5104838a55ab4ef6375f7d3
3 N1175d70d5e33456a8f244717614cd798
4 N180bce0862b04f958ac9358417444e3f
5 N3521ac2434f04e2fba6e690109b9597f
6 N474482bb529d4262a8f0d8e6a5c1e491
7 N55a5c9186da0481f97b35ee45fc4a09c
8 N56bae0682c1441bb9f17e888f9134ce6
9 N6e03b0de3f154968a4c2a5ed75b6580f
10 N86b35fe05dfc465cbe47b8a74a7891c3
11 N94872be697f74761bc4f126ea23fd429
12 Na48f3f7b589b46d989f541e1813c3b2f
13 Na914abbc060a4dd4b75123e58d06edd8
14 Naadda8152be84466a8772b9cede172cf
15 Nc47ec5c02dd546b0ac47d5f7081080d9
16 Nf73874e0596f41b3ad9ad00ae260ccc7
17 anzsrc-for:11
18 anzsrc-for:1102
19 schema:author N2956d73a76d943b8a5b0374a3aba4d42
20 schema:datePublished 1985-06
21 schema:datePublishedReg 1985-06-01
22 schema:description Sixty-six patients who underwent endomyocardial biopsy for detection of mitoxantrone (Novantrone®; dihydroxyanthracenedione) cardiac toxicity were evaluated. All but one had breast cancer, 29 had received prior doxorubicin and 29 of the 37 patients who had not had prior doxorubicin received it or another anthracycline subsequently. Endomyocardial biopsy was carried out initially after four courses of chemotherapy with increasing intervals thereafter. Although cardiac ejection fraction was determined before each course of chemotherapy, our data are limited to cardiac ejection fractions from our own institution which were repeated approximately every four courses. Endomyocardial biopsy changes consisting of dilatation of the sarcoplasmic reticulum with vacuole formation, and myofibrillar dropout are similar to the early changes of anthracycline cardiomyopathy.While there was a slight suggestion of increasing biopsy grade with increasing mitoxantrone dose, no significant changes in cardiac ejection fraction could be associated, regardless of prior doxorubicin therapy. We concluded that mitoxantrone does show morphologic evidence of cardiac toxicity; however, the structural changes are minor and are haemodynamically insignificant. Determination of how much mitoxantrone treatment may contribute to the deterioration of pre-existing doxorubicin damage must await the outcome of longer follow-up.
23 schema:genre article
24 schema:isAccessibleForFree false
25 schema:isPartOf N3fc192e5ce5f485598b94b58d5f7ef9d
26 N988c54553fd34f41a23145f6df7f0b6e
27 sg:journal.1094201
28 schema:keywords angiography
29 anthracyclines
30 biopsy
31 biopsy changes
32 biopsy grade
33 breast cancer
34 cancer
35 cardiac ejection fraction
36 cardiac toxicity
37 changes
38 chemotherapy
39 course
40 courses of chemotherapy
41 damage
42 data
43 detection
44 deterioration
45 determination
46 dilatation
47 dose
48 doxorubicin
49 doxorubicin therapy
50 dropout
51 early changes
52 ejection fraction
53 endomyocardial biopsy
54 evaluation
55 evidence
56 formation
57 fraction
58 grade
59 institutions
60 interval
61 mitoxantrone
62 mitoxantrone dose
63 mitoxantrone treatment
64 morphologic evidence
65 nuclear angiography
66 outcomes
67 own institution
68 patients
69 prior doxorubicin therapy
70 reticulum
71 sarcoplasmic reticulum
72 significant changes
73 slight suggestion
74 structural changes
75 suggestions
76 therapy
77 toxicity
78 treatment
79 update
80 vacuole formation
81 schema:name Evaluation of mitoxantrone cardiac toxicity by nuclear angiography and endomyocardial biopsy: an update
82 schema:pagination 117-121
83 schema:productId N40cfc675c04d4a86a9ba273bd7212874
84 N76988af4d4d14f02830777c845b7ab52
85 Nb2d836da83954bfd8afa69ad2f4c7e64
86 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005025040
87 https://doi.org/10.1007/bf00174158
88 schema:sdDatePublished 2022-11-24T20:46
89 schema:sdLicense https://scigraph.springernature.com/explorer/license/
90 schema:sdPublisher N543cfe5092b94a21b5755ad61f4e57e4
91 schema:url https://doi.org/10.1007/bf00174158
92 sgo:license sg:explorer/license/
93 sgo:sdDataset articles
94 rdf:type schema:ScholarlyArticle
95 N07950c68e4064a93884635a0afb39189 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Antineoplastic Agents
97 rdf:type schema:DefinedTerm
98 N08d86d0eb5104838a55ab4ef6375f7d3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Doxorubicin
100 rdf:type schema:DefinedTerm
101 N1175d70d5e33456a8f244717614cd798 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Breast Neoplasms
103 rdf:type schema:DefinedTerm
104 N180bce0862b04f958ac9358417444e3f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Female
106 rdf:type schema:DefinedTerm
107 N2956d73a76d943b8a5b0374a3aba4d42 rdf:first sg:person.01200333274.18
108 rdf:rest N3d7d5e0dac7b4ad9a0ea26a3f158f98d
109 N3521ac2434f04e2fba6e690109b9597f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Microscopy, Electron
111 rdf:type schema:DefinedTerm
112 N3d7d5e0dac7b4ad9a0ea26a3f158f98d rdf:first sg:person.0661314541.57
113 rdf:rest N4622095c2a2e4792af9d2bbd3621a988
114 N3fc192e5ce5f485598b94b58d5f7ef9d schema:issueNumber 2
115 rdf:type schema:PublicationIssue
116 N40cfc675c04d4a86a9ba273bd7212874 schema:name dimensions_id
117 schema:value pub.1005025040
118 rdf:type schema:PropertyValue
119 N4622095c2a2e4792af9d2bbd3621a988 rdf:first sg:person.01205616545.22
120 rdf:rest Nea5f66e66a424a50b802c118bdb3bb9f
121 N474482bb529d4262a8f0d8e6a5c1e491 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Aged
123 rdf:type schema:DefinedTerm
124 N543cfe5092b94a21b5755ad61f4e57e4 schema:name Springer Nature - SN SciGraph project
125 rdf:type schema:Organization
126 N55a5c9186da0481f97b35ee45fc4a09c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Mitoxantrone
128 rdf:type schema:DefinedTerm
129 N56bae0682c1441bb9f17e888f9134ce6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Biopsy
131 rdf:type schema:DefinedTerm
132 N6e03b0de3f154968a4c2a5ed75b6580f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Humans
134 rdf:type schema:DefinedTerm
135 N76988af4d4d14f02830777c845b7ab52 schema:name doi
136 schema:value 10.1007/bf00174158
137 rdf:type schema:PropertyValue
138 N86b35fe05dfc465cbe47b8a74a7891c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Myocardium
140 rdf:type schema:DefinedTerm
141 N94872be697f74761bc4f126ea23fd429 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Anthraquinones
143 rdf:type schema:DefinedTerm
144 N988c54553fd34f41a23145f6df7f0b6e schema:volumeNumber 3
145 rdf:type schema:PublicationVolume
146 Na48f3f7b589b46d989f541e1813c3b2f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Angiocardiography
148 rdf:type schema:DefinedTerm
149 Na7e5e1b8d550493a8577162341486cb9 rdf:first sg:person.0633513567.35
150 rdf:rest Ncaba3879798644a8bb538bb7a4372779
151 Na914abbc060a4dd4b75123e58d06edd8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Middle Aged
153 rdf:type schema:DefinedTerm
154 Naadda8152be84466a8772b9cede172cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Heart
156 rdf:type schema:DefinedTerm
157 Nb2d836da83954bfd8afa69ad2f4c7e64 schema:name pubmed_id
158 schema:value 4019116
159 rdf:type schema:PropertyValue
160 Nc47ec5c02dd546b0ac47d5f7081080d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
161 schema:name Adult
162 rdf:type schema:DefinedTerm
163 Ncaba3879798644a8bb538bb7a4372779 rdf:first sg:person.01347717057.57
164 rdf:rest rdf:nil
165 Nea5f66e66a424a50b802c118bdb3bb9f rdf:first sg:person.0661361305.23
166 rdf:rest Na7e5e1b8d550493a8577162341486cb9
167 Nf73874e0596f41b3ad9ad00ae260ccc7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
168 schema:name Heart Failure
169 rdf:type schema:DefinedTerm
170 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
171 schema:name Medical and Health Sciences
172 rdf:type schema:DefinedTerm
173 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
174 schema:name Cardiorespiratory Medicine and Haematology
175 rdf:type schema:DefinedTerm
176 sg:journal.1094201 schema:issn 0167-6997
177 1573-0646
178 schema:name Investigational New Drugs
179 schema:publisher Springer Nature
180 rdf:type schema:Periodical
181 sg:person.01200333274.18 schema:affiliation grid-institutes:grid.240145.6
182 schema:familyName Benjamin
183 schema:givenName Robert S.
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01200333274.18
185 rdf:type schema:Person
186 sg:person.01205616545.22 schema:affiliation grid-institutes:grid.240145.6
187 schema:familyName Ewer
188 schema:givenName Michael S.
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01205616545.22
190 rdf:type schema:Person
191 sg:person.01347717057.57 schema:affiliation grid-institutes:grid.240145.6
192 schema:familyName Holmes
193 schema:givenName Frankie
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01347717057.57
195 rdf:type schema:Person
196 sg:person.0633513567.35 schema:affiliation grid-institutes:grid.240145.6
197 schema:familyName Mackay
198 schema:givenName Bruce
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0633513567.35
200 rdf:type schema:Person
201 sg:person.0661314541.57 schema:affiliation grid-institutes:grid.240145.6
202 schema:familyName Chawla
203 schema:givenName Sant P.
204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661314541.57
205 rdf:type schema:Person
206 sg:person.0661361305.23 schema:affiliation grid-institutes:grid.240145.6
207 schema:familyName Carrasco
208 schema:givenName C. Humberto
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661361305.23
210 rdf:type schema:Person
211 grid-institutes:grid.240145.6 schema:alternateName Department of Diagnostic Radiology, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, TX, U.S.A.
212 Department of Internal Medicine, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, TX, U.S.A.
213 Department of Medical Oncology, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, TX, U.S.A.
214 Department of Pathology, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, TX, U.S.A.
215 schema:name Department of Diagnostic Radiology, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, TX, U.S.A.
216 Department of Internal Medicine, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, TX, U.S.A.
217 Department of Medical Oncology, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, TX, U.S.A.
218 Department of Pathology, University of Texas System Cancer Center, M.D. Anderson Hospital and Tumor Institute, Houston, TX, U.S.A.
219 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...